Research fellowMemorial Sloan-Kettering Cancer Center
Disclosure information not submitted.
TP53 mutation predicts worse survival and earlier local recurrence in hepatocellular carcinoma treated with transarterial embolization
Monday, March 25, 202412:00 PM – 1:00 PM MT